These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study. Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224 [TBL] [Abstract][Full Text] [Related]
6. CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy. Li Q; Kim J; Balagurunathan Y; Qi J; Liu Y; Latifi K; Moros EG; Schabath MB; Ye Z; Gillies RJ; Dilling TJ Radiat Oncol; 2017 Sep; 12(1):158. PubMed ID: 28946909 [TBL] [Abstract][Full Text] [Related]
7. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy. Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846 [TBL] [Abstract][Full Text] [Related]
8. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Lafata KJ; Hong JC; Geng R; Ackerson BG; Liu JG; Zhou Z; Torok J; Kelsey CR; Yin FF Phys Med Biol; 2019 Jan; 64(2):025007. PubMed ID: 30524018 [TBL] [Abstract][Full Text] [Related]
10. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics. Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876 [TBL] [Abstract][Full Text] [Related]
11. Identification of optimal mother wavelets in survival prediction of lung cancer patients using wavelet decomposition-based radiomic features. Soufi M; Arimura H; Nagami N Med Phys; 2018 Nov; 45(11):5116-5128. PubMed ID: 30230556 [TBL] [Abstract][Full Text] [Related]
13. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis. Haga A; Takahashi W; Aoki S; Nawa K; Yamashita H; Abe O; Nakagawa K Radiol Phys Technol; 2018 Mar; 11(1):27-35. PubMed ID: 29209915 [TBL] [Abstract][Full Text] [Related]
14. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885 [TBL] [Abstract][Full Text] [Related]
15. Integration of Risk Survival Measures Estimated From Pre- and Posttreatment Computed Tomography Scans Improves Stratification of Patients With Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy. Jiao Z; Li H; Xiao Y; Aggarwal C; Galperin-Aizenberg M; Pryma D; Simone CB; Feigenberg SJ; Kao GD; Fan Y Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1647-1656. PubMed ID: 33333202 [TBL] [Abstract][Full Text] [Related]
16. Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. Li Q; Kim J; Balagurunathan Y; Liu Y; Latifi K; Stringfield O; Garcia A; Moros EG; Dilling TJ; Schabath MB; Ye Z; Gillies RJ Med Phys; 2017 Aug; 44(8):4341-4349. PubMed ID: 28464316 [TBL] [Abstract][Full Text] [Related]
17. Multicentric development and evaluation of [ Lucia F; Louis T; Cousin F; Bourbonne V; Visvikis D; Mievis C; Jansen N; Duysinx B; Le Pennec R; Nebbache M; Rehn M; Hamya M; Geier M; Salaun PY; Schick U; Hatt M; Coucke P; Hustinx R; Lovinfosse P Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1097-1108. PubMed ID: 37987783 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the performance of both machine learning models using PET and CT radiomics for predicting recurrence following lung stereotactic body radiation therapy: A single-institutional study. Nemoto H; Saito M; Satoh Y; Komiyama T; Marino K; Aoki S; Suzuki H; Sano N; Nonaka H; Watanabe H; Funayama S; Onishi H J Appl Clin Med Phys; 2024 Jul; 25(7):e14322. PubMed ID: 38436611 [TBL] [Abstract][Full Text] [Related]
19. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061 [TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. Lovinfosse P; Janvary ZL; Coucke P; Jodogne S; Bernard C; Hatt M; Visvikis D; Jansen N; Duysinx B; Hustinx R Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1453-60. PubMed ID: 26830299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]